Anti-Thymocyte Globulin is named as a drug or biological intervention in 2 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) and Daihong Liu (1). Registered phases: Phase 2 and Phase 4. Conditions studied include Neuroblastoma; Hematopoietic Stem Cell Transplantation.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07648992 | Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell Transplantation (ClinicalTrials.gov ↗) Hematopoietic Stem Cell Transplantation |
Phase 4 | Recruiting |
| NCT05303727 | Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma (ClinicalTrials.gov ↗) Neuroblastoma |
Phase 2 | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Neuroblastoma | 1 |
| Hematopoietic Stem Cell Transplantation | 1 |
| Lead sponsor | Trials |
|---|---|
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
| Daihong Liu | 1 |
| Register | Anti-Thymocyte Globulin trials |
|---|---|
| Clinical trials in China | 2 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Anti-Thymocyte Globulin works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Anti-Thymocyte Globulin (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.